UPDATE: BofA/Merrill Lynch Upgrades PTC Therapeutics (PTCT) to Neutral
Tweet Send to a Friend
(Updated - October 4, 2018 4:31 AM EDT)
(updated to add analyst name, price target and comment)BofA/Merrill Lynch analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updated to add analyst name, price target and comment)BofA/Merrill Lynch analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
